









Mercado
/
Acciones
/
nasdaq-tfx
/

Teleflex Inc

TFX

108.420USD

+2.530+2.39%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

4.79BCap. mercado

PérdidaP/E TTM



Teleflex Inc

108.420

+2.530+2.39%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Teleflex Inc Compañía

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

Información de Teleflex Inc



Símbolo de cotizaciónTFX

Nombre de la empresaTeleflex Inc

Fecha de salida a bolsaMar 17, 1980

Director ejecutivoKelly (Liam J)

Número de empleados14100

Tipo de seguridadOrdinary Share

Fin del año fiscalMar 17

Dirección550 E Swedesford Rd

CiudadWAYNE

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal19087

Teléfono16102256800

Sitio Webhttps://www.teleflex.com/usa/en/#

Símbolo de cotizaciónTFX

Fecha de salida a bolsaMar 17, 1980

Director ejecutivoKelly (Liam J)

Ejecutivos de Teleflex Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Liam J. Kelly

Chairman of the Board, President, Chief Executive Officer

50.99K

+1500.00%

Mr. Stuart Allen (Stu) Randle

Independent Director

22.55K

+12325.00%

Mr. Cameron P. Hicks

Corporate Vice President - Human Resources and Communications

10.38K

+1162.00%

Dr. Stephen K. Klasko, M.D.

Lead Independent Director

10.06K

+1357.00%

Mr. Andrew A. (Andy) Krakauer

Independent Director

6.54K

+1000.00%

Ms. Gretchen R. Haggerty

Independent Director

5.66K

+500.00%

Mr. John C. Heinmiller

Independent Director

4.39K

+1051.00%

Dr. Jaewon Ryu, M.D., J.D.

Independent Director

3.08K

+1500.00%

Ms. Neena M. Patil, J.D.

Independent Director

1.98K

+1051.00%

Ms. Candace H. Duncan

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Liam J. Kelly

Chairman of the Board, President, Chief Executive Officer

50.99K

+1500.00%

Mr. Stuart Allen (Stu) Randle

Independent Director

22.55K

+12325.00%

Mr. Cameron P. Hicks

Corporate Vice President - Human Resources and Communications

10.38K

+1162.00%

Dr. Stephen K. Klasko, M.D.

Lead Independent Director

10.06K

+1357.00%

Mr. Andrew A. (Andy) Krakauer

Independent Director

6.54K

+1000.00%

Ms. Gretchen R. Haggerty

Independent Director

5.66K

+500.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Interventional

266.41M

29.18%

Vascular access

191.02M

20.92%

Surgical

122.88M

13.46%

Anesthesia

101.45M

11.11%

OEM

80.41M

8.81%

Otro

150.85M

16.52%

Por regiónUSD

Nombre

Ganancia

Proporción

Americas

555.90M

60.89%

EMEA

234.25M

25.66%

Asia Pacific

122.87M

13.46%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Interventional

266.41M

29.18%

Vascular access

191.02M

20.92%

Surgical

122.88M

13.46%

Anesthesia

101.45M

11.11%

OEM

80.41M

8.81%

Otro

150.85M

16.52%

Estadísticas de accionistas

Actualizado: jue., 29 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.05%

The Vanguard Group, Inc.

10.72%

T. Rowe Price Investment Management, Inc.

10.34%

Janus Henderson Investors

9.42%

AQR Capital Management, LLC

5.35%

Otro

53.12%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.05%

The Vanguard Group, Inc.

10.72%

T. Rowe Price Investment Management, Inc.

10.34%

Janus Henderson Investors

9.42%

AQR Capital Management, LLC

5.35%

Otro

53.12%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

57.71%

Investment Advisor/Hedge Fund

35.62%

Hedge Fund

9.18%

Pension Fund

1.88%

Sovereign Wealth Fund

1.36%

Research Firm

0.92%

Bank and Trust

0.58%

Family Office

0.45%

Individual Investor

0.37%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1170

47.51M

107.50%

-2.16M

2025Q3

1153

47.10M

106.58%

-5.30M

2025Q2

1158

48.67M

110.13%

-386.02K

2025Q1

1189

48.85M

110.52%

-721.30K

2024Q4

1180

47.47M

102.37%

-260.40K

2024Q3

1150

46.34M

98.36%

-1.83M

2024Q2

1147

46.98M

99.75%

-268.09K

2024Q1

1153

46.02M

97.70%

-1.89M

2023Q4

1170

46.05M

97.91%

-2.57M

2023Q3

1173

45.95M

97.77%

-3.19M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

4.89M

11.05%

-86.30K

-1.74%

Sep 30, 2025

The Vanguard Group, Inc.

4.78M

10.81%

-20.71K

-0.43%

Sep 30, 2025

T. Rowe Price Investment Management, Inc.

4.57M

10.34%

-1.38M

-23.14%

Sep 30, 2025

Janus Henderson Investors

4.16M

9.42%

+12.09K

+0.29%

Sep 30, 2025

AQR Capital Management, LLC

2.37M

5.35%

+1.96M

+478.06%

Sep 30, 2025

Atlanta Capital Management Company, L.L.C.

2.30M

5.21%

-103.20K

-4.29%

Sep 30, 2025

State Street Investment Management (US)

1.46M

3.3%

-3.02K

-0.21%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.25M

2.82%

+3.81K

+0.31%

Sep 30, 2025

Cooke & Bieler, L.P.

1.22M

2.76%

+14.67K

+1.22%

Sep 30, 2025

Abrams Bison Investments, L.L.C.

917.92K

2.08%

+917.92K

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Invesco S&P SmallCap Health Care ETF

3.37%

First Trust Indxx Medical Devices ETF

2.09%

First Trust Health Care Alphadex Fund

1.77%

State Street SPDR S&P Health Care Equipment ETF

1.7%

Zacks Small/Mid Cap ETF

0.85%

State Street SPDR S&P 600 Small Cap Value ETF

0.75%

iShares S&P Small-Cap 600 Value ETF

0.75%

Distillate Small/Mid Cash Flow ETF

0.7%

VictoryShares Small Cap Free Cash Flow ETF

0.68%

iShares MSCI USA Small-Cap Min Vol Factor ETF

0.67%

Invesco S&P SmallCap Health Care ETF

Proporción3.37%

First Trust Indxx Medical Devices ETF

Proporción2.09%

First Trust Health Care Alphadex Fund

Proporción1.77%

State Street SPDR S&P Health Care Equipment ETF

Proporción1.7%

Zacks Small/Mid Cap ETF

Proporción0.85%

State Street SPDR S&P 600 Small Cap Value ETF

Proporción0.75%

iShares S&P Small-Cap 600 Value ETF

Proporción0.75%

Distillate Small/Mid Cash Flow ETF

Proporción0.7%

VictoryShares Small Cap Free Cash Flow ETF

Proporción0.68%

iShares MSCI USA Small-Cap Min Vol Factor ETF

Proporción0.67%

Dividendos



Un total de 254.87M USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Nov 06, 2025

TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2025 going ex on Nov 14, 2025

Nov 14, 2025

Dec 15, 2025

Nov 14, 2025

Jul 31, 2025

TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2025 going ex on Aug 15, 2025

Aug 15, 2025

Sep 15, 2025

Aug 15, 2025

May 12, 2025

TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 16, 2025 going ex on May 20, 2025

May 20, 2025

Jun 16, 2025

May 20, 2025

Feb 27, 2025

TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025

Mar 07, 2025

Mar 17, 2025

Mar 07, 2025

Oct 31, 2024

TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Dec 16, 2024

Nov 15, 2024

Aug 01, 2024

TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024

Aug 15, 2024

Sep 16, 2024

Aug 15, 2024

May 06, 2024

TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024

May 15, 2024

Jun 14, 2024

May 14, 2024

Feb 22, 2024

TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Mar 15, 2024

Feb 29, 2024

Nov 02, 2023

TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023

Nov 15, 2023

Dec 15, 2023

Nov 14, 2023

Aug 03, 2023

TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023

Aug 15, 2023

Sep 15, 2023

Aug 14, 2023

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

